
There are already more U.S. measles cases this year than in all of 2025
The number of measles cases in the U.S. has surpassed the record-breaking tally for all of 2025, with five more months…
Read at source →Source
Medicine, biotech, and health policy
Health · 702 articles · page 19 of 20 · fetched about 1 hour ago

The number of measles cases in the U.S. has surpassed the record-breaking tally for all of 2025, with five more months…
Read at source →
From new hires to departures, promotions, and hires, here are the latest comings and goings in the pharma industry.
Read at source →
Sanofi insulin pen in short supply, a win for peptide compounds, and more biotech news from The Readout
Read at source →
AdSee who you follow, newest first. Free to join. Posts that stay visible — not buried by an algo.
Join siguimi.com →
In a win for peptide proponents, an FDA advisory panel recommended compounding pharmacies be allowed to make four of…
Read at source →
A win for peptide proponents, autism advisory committees clash, and more health news from Morning Rounds
Read at source →
Merck is striking licensing deals for its experimental HIV prevention pill in hope of getting wide-scale production…
Read at source →
The Trump administration released its blueprint for U.S. science, calling for shifting hundreds of billions of research…
Read at source →
Unexpected alliances among Republicans and Democrats were on display over a bill meant to rein in ultra-processed foods.
Read at source →
The national security framing of the discussion around pharmaceutical supply chain vulnerabilities is a distraction,…
Read at source →
A federal loan program made it possible for Gauri Gurumurthy to pursue medicine. Now that program is changing.
Read at source →
The panel recommended allowing compounding pharmacies to produce popular but unproven BPC-157 and KPV peptides.
Read at source →
Federal health officials are investigating a new outbreak involving the diarrhea-causing parasite cyclospora.
Read at source →
The European Medicines Agency is taking what advocacy groups are calling unexpectedly “rapid action” to ensure that…
Read at source →
The Lantus Solostar insulin pen isn't in official FDA shortage, but patients are having a tough time finding it.
Read at source →
Too few senators were in attendance to proceed with a vote on the CDC director nominee.
Read at source →
Congress is scrambling to advance a slew of health care bills before an August recess. Price transparency and prior…
Read at source →
Today's biotech news features the FDA weighing the fate of peptides; approvals for RevMed, GSK; and data on Lilly's…
Read at source →
Has a wanted fugitive been posing as a biotech executive? And what does it take to develop a therapy for an ultra-rare…
Read at source →
Sean Kaufman, nominated to run ASPR, has a track record of questioning the safety of vaccines.
Read at source →
Timothy Westlake, an emergency doctor nominated to head SAMHSA, has been active in addiction policy in Wisconsin.
Read at source →
A study of Lilly's retatrutide weight loss drug in people with heart disease did not answer a crucial question —…
Read at source →
In this edition of STAT Health Tech: HHS is inviting experts to shape policy on clinical AI, Whoop's new CMO, news…
Read at source →
A leading advocacy group petitioned the FDA to ban direct-to-consumer advertising of prescription medicines.
Read at source →
The service members who refused the Covid vaccine, the fastest-growing Ebola outbreak in history, and other health news…
Read at source →
On analyses that looked at major cardiovascular events, those taking retatrutide did not have a significant lower risk…
Read at source →
Mirroring the bipartisan bill introduced in the House, the measure would require a study from the GAO on the state of…
Read at source →
FDA advisers are set to consider whether allowing compounding pharmacies to offer largely unproven peptides is a safer…
Read at source →
New maternal billing codes should create a transparent system where both patients and clinicians can thrive, ACOG…
Read at source →
“This change is likely to lead to only modest increases in total medical expenses. However, it coincides with many…
Read at source →
Veterans who want to rejoin the military are often bogged down in bureaucratic red tape.
Read at source →
In this edition of AI Prognosis, Brittany Trang talks to Alex LeBrun, AI scribe company Nabla's executive chairman,…
Read at source →
New data supports the idea that Merck’s Ebola vaccine Ervebo, licensed to target the Zaire species of ebolaviruses,…
Read at source →
“Hospitals often make Argentina’s mistake: We confuse continuity with progress,” writes physician, hospital…
Read at source →
At least 999 people have died from the Ebola outbreak in Congo, a grim toll in what’s already been declared the fastest…
Read at source →
At least 999 people have died from the Ebola outbreak in Congo, a grim toll in what’s already been declared the fastest…
Read at source →
AI-focused VC firm raises $800M, Merck's new cholesterol pill, and more biotech news from The Readout
Read at source →